These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 25161381

  • 1. Use of fine particle ethylcellulose as the diluent in the production of pellets by extrusion-spheronization.
    Mallipeddi R, Saripella KK, Neau SH.
    Saudi Pharm J; 2014 Sep; 22(4):360-72. PubMed ID: 25161381
    [Abstract] [Full Text] [Related]

  • 2. Use of extrusion aids for successful production of Kollidon® CL-SF pellets by extrusion-spheronization.
    Loka NC, Saripella KK, Pinto CA, Neau SH.
    Drug Dev Ind Pharm; 2018 Apr; 44(4):632-642. PubMed ID: 29183166
    [Abstract] [Full Text] [Related]

  • 3. Use of coarse ethylcellulose and PEO in beads produced by extrusion-spheronization.
    Mallipeddi R, Saripella KK, Neau SH.
    Int J Pharm; 2010 Jan 29; 385(1-2):53-65. PubMed ID: 19853027
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of microcrystalline cellulose grade and process variables on pellets prepared by extrusion-spheronization.
    Alvarez L, Concheiro A, Gómez-Amoza JL, Souto C, Martínez-Pacheco R.
    Drug Dev Ind Pharm; 2002 Apr 29; 28(4):451-6. PubMed ID: 12056538
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Extrusion/spheronization--effect of moisture content and spheronization time on pellet characteristics.
    Iyer RM, Augsburger LL, Pope DG, Shah RD.
    Pharm Dev Technol; 1996 Dec 29; 1(4):325-31. PubMed ID: 9552316
    [Abstract] [Full Text] [Related]

  • 12. The influence of microcrystalline cellulose grade on shape and shape distributions of pellets produced by extrusion-spheronization.
    Koo OM, Heng PW.
    Chem Pharm Bull (Tokyo); 2001 Nov 29; 49(11):1383-7. PubMed ID: 11724226
    [Abstract] [Full Text] [Related]

  • 13. MUPS Tableting-Comparison between Crospovidone and Microcrystalline Cellulose Core Pellets.
    Thio DR, Heng PWS, Chan LW.
    Pharmaceutics; 2022 Dec 15; 14(12):. PubMed ID: 36559308
    [Abstract] [Full Text] [Related]

  • 14. A Quality by Experimental Design Approach to Assess the Effect of Formulation and Process Variables on the Extrusion and Spheronization of Drug-Loaded Pellets Containing Polyplasdone® XL-10.
    Saripella KK, Loka NC, Mallipeddi R, Rane AM, Neau SH.
    AAPS PharmSciTech; 2016 Apr 15; 17(2):368-79. PubMed ID: 26169900
    [Abstract] [Full Text] [Related]

  • 15. Extruded and spheronized beads containing no microcrystalline cellulose: influence of formulation and process variables.
    Agrawal AM, Howard MA, Neau SH.
    Pharm Dev Technol; 2004 Apr 15; 9(2):197-217. PubMed ID: 15202579
    [Abstract] [Full Text] [Related]

  • 16. Formulation and Optimization of Lansoprazole Pellets Using Factorial Design Prepared by Extrusion-Spheronization Technique Using Carboxymethyl Tamarind Kernel Powder.
    Muley SS, Nandgude T, Poddar S.
    Recent Pat Drug Deliv Formul; 2017 Apr 15; 11(1):54-66. PubMed ID: 28088896
    [Abstract] [Full Text] [Related]

  • 17. Functionality of cross-linked polyvinylpyrrolidone as a spheronization aid: a promising alternative to microcrystalline cellulose.
    Liew CV, Gu L, Soh JL, Heng PW.
    Pharm Res; 2005 Aug 15; 22(8):1387-98. PubMed ID: 16078149
    [Abstract] [Full Text] [Related]

  • 18. Use of chitosan-alginate as alternative pelletization aid to microcrystalline cellulose in extrusion/spheronization.
    Charoenthai N, Kleinebudde P, Puttipipatkhachorn S.
    J Pharm Sci; 2007 Sep 15; 96(9):2469-84. PubMed ID: 17286294
    [Abstract] [Full Text] [Related]

  • 19. Properties of drug-containing spherical pellets produced by a hot-melt extrusion and spheronization process.
    Young CR, Koleng JJ, McGinity JW.
    J Microencapsul; 2003 Sep 15; 20(5):613-25. PubMed ID: 12909545
    [Abstract] [Full Text] [Related]

  • 20. Dissolution rate improvement of telmisartan through modified MCC pellets using 32 full factorial design.
    Patel H, Patel H, Gohel M, Tiwari S.
    Saudi Pharm J; 2016 Sep 15; 24(5):579-587. PubMed ID: 27752231
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.